intranasal bpc-157 human study & TB-500 Research Peptide SET BPC-157 + TB-500 Nasal Spray

This level suits researchers primarily interested in metabolic health improvements like insulin sensitivity and lipid panel normalization, where extreme weight loss is not the primary goal

Mitochondrial peptides like SS-31 and MOTS-c target cellular energy production in the brain

Unlike compounds such as tesamorelin , which completed Phase III clinical trials and received FDA approval, TB-500 remains entirely in the preclinical research domain

Peripheral peptide hormones are released postprandially and travel in the circulation to bind to their receptors in the homeostatic regulatory centers in the CNS, notably the arcuate nucleus (ARC) of the hypothalamus and the dorsal vagal complex (DVC) in the brainstem medulla

This means you need proportionally higher doses via nasal spray to achieve similar systemic peptide levels